VIE/FYB (VIE/FYB)

Vienna Stock Exchange: VIE/FYB · EUR

€19.2

-0.04 (-0.2%)· Recorded snapshot

Market cap	337.6M
Revenue (ttm)	61.2M
Net income (ttm)	-25.1M
EPS (ttm)	-€1.42
P/E (forward)	75.7x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 61.2M
Net income (ttm): -25.1M
EPS (ttm): -€1.42
P/E (forward): 75.7x
Market cap: 337.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E75.7

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-6.3

P25 n/aP50 n/aP75 n/a

ROIC-4.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/FYB indicators

Market & fundamental data

Available fields

155

Groups with data

Currency

EUR

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-12
Employees	196
Employees change	-47
Employees growth	-18.8%
Enterprise value	EUR 294.3M
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1999
Industry	Biotechnology
Is primary listing	No
ISIN number	DE000A1EWVY8
Last earnings date	2026-08-12
Last refreshed	2026-10-30
Market cap	EUR 337.6M
Next earnings date	2026-11-12
Price	EUR 19.18
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	vie/FYB
Website	https://www.formycon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-7.42%
EV/Sales	4.81x
FCF / EV yield	-0.67%
FCF yield	-0.58%
Forward P/E	75.73x
P/B ratio	0.88x
P/S ratio	5.51x
Price/EBITDA ratio	35.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-24.25%
EBITDA margin	15.36%
Gross margin	22.81%
Operating margin	-24.25%
Pretax margin	-84.37%
Profit margin	-41.04%
Profit per employee	EUR -128,224
Revenue per employee	EUR 312,459
ROA	-1.27%
ROA (5Y)	-3.64%
ROCE	-2.25%
ROE	-6.33%
ROE (5Y)	-5.53%
ROIC	-4.09%
ROIC (5Y)	-12.53%
SBC / revenue	3.57%
Tax / revenue	-43.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth 3Y	-16.94%
Gross profit growth 5Y	12.39%
Net income growth years	1
Revenue growth	18.28%
Revenue growth (Q)	242.52%
Revenue growth (QoQ)	-3.34%
Revenue growth 10Y	14.46%
Revenue growth 3Y	-3.73%
Revenue growth 5Y	10.12%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -739,000
Depreciation and amortization	EUR 24.3M
EBIT	EUR -14.9M
EBITDA	EUR 9.4M
EPS	EUR -1.42
Financing cash flow	EUR 50.3M
Free cash flow	EUR -2M
Free cash flow minus SBC	EUR -4.1M
Gross profit	EUR 14M
Income taxes	EUR -26.5M
Investing cash flow	EUR -24.6M
Net borrowing	EUR 58.9M
Net cash flow	EUR 24.5M
Net income	EUR -25.1M
Operating cash flow minus SBC	EUR -3.4M
Operating income	EUR -14.9M
Revenue	EUR 61.2M
Stock-based compensation	EUR 2.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.59
Book value per share	EUR 21.82
Debt / EBITDA	0.79
Debt / equity	0.02
Long-term assets	EUR 603.5M
Long-term liabilities	EUR 274M
Net cash (debt)	EUR 43.3M
Net cash / market cap	12.82%
Net cash growth	153.43%
Net debt / EBITDA	-4.6
Net debt / equity	-0.11
Piotroski F-Score	4
Property, plant and equipment	EUR 12.3M
Shareholders' equity	EUR 385.6M
Tangible book value	EUR -27.6M
Tangible book value per share	EUR -1.56
Total assets	EUR 713.6M
Total cash	EUR 51.8M
Total debt	EUR 8.5M
Total liabilities	EUR 328M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.08
Current assets	EUR 110.1M
Current liabilities	EUR 54M
Current ratio	2.04
Inventory turnover	10.43
Net working capital	EUR 5.4M
Quick ratio	1.42
Working capital	EUR 56.1M
Working capital turnover	1.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.06%
Shareholder yield	0.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	-0.21%
1M price change	0.63%
1M total return	0.63%
1W price change	0.1%
1W total return	0.1%
20-day SMA	EUR 19.44
3M price change	1.81%
3M total return	1.81%
50-day SMA	EUR 19.64
52-week high	EUR 22.50
52-week high date	2026-05-29
52-week low	EUR 17.18
52-week low date	2026-04-13
6M price change	7.27%
6M total return	7.27%
All-time high	EUR 22.50
All-time high date	2026-05-29
All-time low	EUR 17.18
All-time low date	2026-04-13
Average true range (ATR)	EUR 0.50
Average volume	0
Change from 52-week high	-14.76%
Change from 52-week low	11.64%
Change from all-time high	-14.76%
Change from all-time low	11.64%
Change from open	-0.21%
Day's gap	0%
High price	EUR 19.30
Low price	EUR 19.16
Monthly RSI	0
Open price	EUR 19.22
Position in 52-week range	14.29%
Previous close	EUR 19.22
Price vs 20-day SMA	-1.35%
Price vs 50-day SMA	-2.36%
Relative volume	11.07
RSI	45.74
Sharpe ratio	0.48
Sortino ratio	0.91
Weekly RSI	53.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (YoY)	-0.06%
Shares held by institutions	1.88%

Deeper analysis on VIE/FYB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/FYB report

Is a complete VIE/FYB research report available?

No complete published report is available for vie/FYB (VIE/FYB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/FYB (VIE/FYB)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/FYB

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/FYB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/FYB

Frequently asked questions